Duke University Medical Center Dept. of DUMC (4)

Durham, North Carolina 27710

0 studies enrolling now · 2 studies all time

What they study most

Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Relapsed and Bortezomib Refractory Multiple Myeloma, Relapsed or Refractory Multiple Myeloma

Studies at this site

• Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation — Completed
• Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma — Completed